https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/draft-guidance-document-biopharmaceutics-classification-system-based-biowaiver.html
Draft Guidance Document - Biopharmaceutics Classification System Based Biowaiver - Canada.ca
2012 Health Canada consultation notice (comment period ending November 19, 2012)
draft guidanceclassification systemdocumentbiopharmaceuticsbased
https://pubmed.ncbi.nlm.nih.gov/31155721/
Demonstrating suitability of the Caco-2 cell model for BCS-based biowaiver according to the recent...
Assay standardisation assures the consistency of experimental data. Only such fully characterised model has the ability to accurately predict drug's intestinal...